This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ANDREW deROETTH, Jr., M.D.

Arch Ophthal. 1949;42(4):365-372.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE EFFECTIVE use of aureomycin in treatment of several external infections of the eye has been reported by Braley.¹ Because of the possibility that aureomycin may be of value also for intraocular infections, the current study was undertaken to determine the penetration of this new antibiotic into rabbit eyes following various methods of administration.

TECHNIC

Topical Application.

—The technic as described by von Sallmann² was used in iontophoresis, the corneal bath and subconjunctival injection. A fresh solution of 0.5 per cent aureomycin borate was made daily, distilled water being used as the solvent. After production of local anesthesia with 6 drops of 0.1 per cent dibucaine hydrochloride (nupercaine hydrochloride^®), the applicator tube was filled to the halfway mark (2.5 to 3.0 cc. of solution). At the end of the procedure the excess fluid was carefully removed, and about 0.25 cc. of aqueous was withdrawn at stated intervals . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Department of Opthalmology, Columbia University College of Physicians and Surgeons, and the Institute of Ophthalmology, Presbyterian Hospital.

Footnotes
This study was supported in part by the Knapp Memorial Foundation.

The aureomycin for these experiments was obtained from Lederle Laboratories Division, American Cyanamid Company, Pearl River, N. Y.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?